✨ Miscellaneous Notices
NEW ZEALAND GAZETTE, No. 13 — 5 FEBRUARY 2015
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Imiquimod Cream
Active Ingredient: Imiquimod 50mg/g
Dosage Form: Topical cream
New Zealand Sponsor: Orion Laboratories (NZ) Limited
Manufacturer: Perrigo Israel Pharmaceuticals Limited, Yeruham, Israel
Dated this 30th day of January 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go596
Marriage Celebrants for 2015 Notice No. 13
Pursuant to the provisions of section 13 of the Marriage Act 1955, it is hereby notified that the following names will be removed from the list of marriage celebrants under sections 8 and 10 of the Act as at 19 February 2015:
Laird, Ian, Presbyterian Church of Aotearoa NZ.
Moss, Richard William, The Independent Church in New Zealand.
Muzondiwa, Amos, Presbyterian Church of Aotearoa NZ.
Poon, Daniel Shik Kwan, City Blessings Church.
Dated at Wellington this 5th day of February 2015.
JEFF MONTGOMERY, Registrar-General.
2015-go627
Notice of Application to Register a Trade Name Product (Notice No. MPI 454)
Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“the Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:
Trade Name: Tildren 500mg lyophilisate for solution for infusion
Reference: A11167
Active Ingredient and Concentration:
Tiludronic acid (as disodium tiludronate) 500mg/vial
Formulation Type: Freeze-dried powder for reconstitution with an isotonic solution
General Use Claim:
For the treatment for lameness associated with bone and cartilage changes in horses.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
a. must state in full the reasons for making the submission; and
b. may state any decision sought on that application; and
c. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.
47
Next Page →
✨ LLM interpretation of page content
🏥
Consent to the Distribution of a New Medicine
(continued from previous page)
🏥 Health & Social Welfare30 January 2015
Medicines, Consent, Distribution, Imiquimod Cream, Orion Laboratories, Perrigo Israel Pharmaceuticals
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
🏛️ Marriage Celebrants for 2015 Notice No. 13
🏛️ Governance & Central Administration5 February 2015
Marriage Celebrants, Removal, Presbyterian Church, Independent Church, City Blessings Church
- Ian Laird, Removed from list of marriage celebrants
- Richard William Moss, Removed from list of marriage celebrants
- Amos Muzondiwa, Removed from list of marriage celebrants
- Daniel Shik Kwan Poon, Removed from list of marriage celebrants
- JEFF MONTGOMERY, Registrar-General
🏭 Notice of Application to Register a Trade Name Product (Notice No. MPI 454)
🏭 Trade, Customs & IndustryTrade Name Registration, Tildren 500mg, Tiludronic acid, Veterinary Medicine, MPI
- Maree Zinzley, Manager Approvals Operations, Ministry for Primary Industries
NZ Gazette 2015, No 13